Johannes M. Weller
Bonn, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
Potential for donation after circulatory death in Germany: a multicenter retrospective study at seven university hospitals.
Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: June 23, 2026
Real-World Validation of the HERMES-24 Score for Outcome Prediction After Large Vessel Occlusion Treatment in Late Time Window Patients.
Journal: Neurology
Published: May 14, 2026
APTw CEST MRI in therapy-naive IDH-wildtype glioblastoma: insights into tumor heterogeneity and molecular subtypes.
Journal: Journal of neuro-oncology
Published: March 27, 2026
Lomustine with or without procarbazine in recurrent glioblastoma-A propensity score matching analysis.
Journal: Neuro-oncology advances
Published: February 20, 2026
Swarm Learning for the Detection of Middle Cerebral Artery Occlusion On CT Angiography.
Journal: Clinical neuroradiology
Published: February 03, 2026
Impact of Severe Prestroke Disability on Outcomes After Mechanical Thrombectomy: A Multicenter Analysis.
Journal: Stroke (Hoboken, N.J.)
Published: August 07, 2025
ADHD traits and financial decision making in stock trading.
Journal: Scientific reports
Published: July 07, 2025
Second-line temozolomide in first recurrent MGMT-methylated glioblastoma after lomustine/temozolomide: Efficacy and safety.
Journal: Neuro-oncology advances
Published: June 27, 2025
Portable ultra-low-field MRI in acute stroke care: A pilot study.
Journal: European stroke journal
Published: June 14, 2025
Patterns and predictors of delayed functional independence and dependence after thrombectomy in large vessel occlusion stroke: A multicenter analysis.
Journal: European stroke journal
Published: June 12, 2025
Factors Associated With Relapse in Patients With Neurosarcoidosis.
Journal: Neurology
Published: May 15, 2025
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial.
Journal: Nature communications
Published: May 01, 2025
Last Updated: 09/26/2026